VBIO

Valion Bio, Inc.

Healthcare · Biotechnology

$221.14 sample

+0.36 (+0.16%) 1D

Market cap

$926.7B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-30

Alerts

8

Price$221.14 +5.89% 3M daily closessample

228.68208.83

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30SEC10-Q filed
Sep 25INSInsider buy: Chief Executive Officer
Sep 17INSInsider sell: Chief Financial Officer
Sep 08INSInsider sell: Chief Financial Officer
Aug 28INSInsider buy: Chief Financial Officer
Aug 19INSInsider sell: EVP, Operations
Aug 11SEC8-K filed: material event
Jul 31INSInsider buy: General Counsel

Sign up to see the real VBIO record →

Company facts

SEC EDGAR registration

Name: Valion Bio, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -2sample, -100 to +100
Reporting currency: USD

Who is positioning in VBIO

sample

Insiders: 6 insider transactions over 90 days, net selling, $145.3M
Congress: 1 members traded over 90 days
Institutions · 13F: 35 funds hold $17.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$37.8B +18.2% y/y

Q4 2024Q3 2026

Inventory$22.3B +11.9% y/y

Q4 2024Q3 2026

Accounts receivable$17.1B +12.0% y/y

Q4 2024Q3 2026

Total debt$46.7B +12.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $318.3B -8.3% 3M
Sample peer B: $456.1B +8.5% 3M
Sample peer C: $529.5B +11.2% 3M
Sample peer D: $607.3B +7.6% 3M
Sample peer E: $737.4B -13.2% 3M